[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343531-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-343531-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","senp3-mediates-the-desumoylation-and-degradation-of-yap1-to-regulate-the-progression-of-triple-negative-breast-cancer-research-article","SENP3 mediates the deSUMOylation and degradation of YAP1 to regulate the progression of triple-negative breast cancer - Research Article","","SENP3, a nucleolus-localized SUMO-specific protease, is investigated for its role in triple-negative breast cancer (TNBC). The study shows SENP3 suppresses TNBC cell migration, invasion, and stem cell–like traits. YAP1 is identified as a downstream target: SENP3 deconjugates SUMOylated YAP1 and promotes its ubiquitin-proteasome–mediated degradation. A YAP1 SUMOylation-site mutation blocks the tumorigenic capacity of wild-type YAP1 in TNBC, establishing SENP3-dependent YAP1 regulation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/senp3-mediates-the-desumoylation-and-degradation-of-yap1-to-regulate-the-progression-of-triple-negative-breast-cancer-research-article/343531/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/senp3-mediates-the-desumoylation-and-degradation-of-yap1-to-regulate-the-progression-of-triple-negative-breast-cancer-research-article/343531.png","ImageObject",300,407,{"name":42,"@type":43},"Sage","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does SENP3 play in triple-negative breast cancer cells?","Question",{"text":63,"@type":64},"SENP3 inhibits TNBC cell migration and invasion and reduces stem cell–like phenotypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SENP3 regulate YAP1?",{"text":68,"@type":64},"SENP3 deconjugates SUMOylated YAP1 and promotes its degradation through the ubiquitin-proteasome system.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is YAP1 SUMOylation important for TNBC tumorigenesis?",{"text":72,"@type":64},"A mutation at the YAP1 SUMOylation site prevents the tumorigenic capacity seen with wild-type YAP1, indicating the process is required for SENP3-dependent effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343531,1790186415,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","RESEARCH ARTICLE  \nSENP3 mediates the deSUMOylation and degradation of YAP1 to regulate the progression of triple-negative breast cancer  \nReceived for publication, March 17, 2024, and in revised form, July 23, 2024 Published, Papers in Press, September 11, 2024, [https://doi.org/10.1016/j.jbc.2024.107764](https://doi.org/10.1016/j.jbc.2024.107764)  \nXu Chen 1,†, Danqing Li 1,†, Qi Su 1,†, Xing Ling 1, Yanyan Yang 1, Yuhang Liu 1, Xinjie Zhu 1, Anqi He 1, Siyu Ding 1, Runxiao Xu 1, Zhaoxia Liu 1, Xiaojun Long 1, Jinping Zhang2, Zhihui Yang2, Yitao Qi 1, *, and Hongmei Wu 1, * From the 1College of Life Sciences, Shaanxi Normal University, Xi’an, Shaanxi, China; 2Department of Pathology, The Afﬁliated  \nHospital of Southwest Medical University, Luzhou, Sichuan, China Reviewed by members of the JBC Editorial Board. Edited by Paul Shapiro  \nTriple-negative breast cancer (TNBC) is a prevalent malignancy in women, casting a formidable shadow on their well-being. Positioned within the nucleolus, SUMO-speciﬁc protease 3 (SENP3) assumes a pivotal role in the realms of development and tumorigenesis. However, the participation of SENP3 in TNBC remains a mystery. Here, we elucidate that SENP3 exerts inhibitory effects on migration and invasion capacities, as well as on the stem cell–like phenotype, within TNBC cells. Further experiments showed that YAP1 is the downstream target of SENP3, and SENP3 regulates tumorigenesis in a YAP1-dependent manner. YAP1 is found to be SUMOylated and SENP3 deconjugates SUMOylated YAP1 and promotes degradation mediated by the ubiquitin-proteasome system. More importantly, YAP1 with a mutation at the SUMOylation site impedes the capacity ofWT YAP1 in TNBC tumorigenesis. Taken together, our ﬁndings ﬁrmly establish the pivotal role of SENP3 in the modulation of YAP1 deSUMOylation, unveiling novel mechanistic insight into the important role of SENP3 in the regulation of TNBC tumorigenesis in a YAP1-dependent manner.  \nBreast carcinoma presents a formidable public health conundrum, characterized by a considerable mortality rate (1–3). Remarkably, triple-negative breast cancer (TNBC), marked by its lack of estrogen receptor, progesterone receptor, and human epidermal growth factor 2 receptor expression, manifests inherent aggressiveness, accompanied by a bleak prognostic outlook (4–6). This variant encompasses 15 to 26% of the entire population of breast cancer patients (7–9). The increased propensity ofTNBC to metastasize to healthy organs and its higher recurrence rate further contribute to its elevated mortality and unfavorable prognosis, making it the most malignant breast cancer subtype (10–12). Currently, the therapeutic approach to TNBC is based primarily on surgical interventions, chemotherapy regimens, and radiation therapy protocols. However, the absence of estrogen receptor,  \n† These authors contributed equally to the work.  \n* For correspondence: Yitao Qi, [qiyitao@snnu.edu.cn](qiyitao@snnu.edu.cn); Hongmei Wu, [hq8479@snnu.edu.cn](hq8479@snnu.edu.cn).  \nprogesterone receptor, and human epidermal growth factor 2 receptor poses a formidable challenge in the application of conventional cancer treatments to patients with TNBC with optimal efﬁcacy. Therefore, identifying the optimal treatment approach for patients with TNBC is particularly urgent.  \nSUMOylation stands as an example of the highly dynamic realm of posttranslational modiﬁcations, wherein the SUMO protein becomes intricately bound, covalently, or noncovalently, to the lysine residue of substrate proteins through a meticulously orchestrated enzyme cascade reaction (13–15). Orchestration of this cascade reaction requires a sequential interaction involving the activating enzyme E1, the binding enzyme E2, and the ligating enzyme E3. SUMOylation is a process susceptible to reversal by the illustrious family of SUMO-speciﬁc proteases (SENPs), within which mammals boast the expression of an impressive array comprising six distinct SENPs, namely SEN","cbCaisakTTvHdehg","https://ap.wps.com/l/cbCaisakTTvHdehg","pdf",5651285,16,"English","# Abstract\n## SENP3 effects in TNBC\n## YAP1 as a downstream target\n## SUMOylation and degradation mechanism\n## Impact of YAP1 SUMOylation-site mutation","[{\"question\":\"What role does SENP3 play in triple-negative breast cancer cells?\",\"answer\":\"SENP3 inhibits TNBC cell migration and invasion and reduces stem cell–like phenotypes.\"},{\"question\":\"How does SENP3 regulate YAP1?\",\"answer\":\"SENP3 deconjugates SUMOylated YAP1 and promotes its degradation through the ubiquitin-proteasome system.\"},{\"question\":\"Why is YAP1 SUMOylation important for TNBC tumorigenesis?\",\"answer\":\"A mutation at the YAP1 SUMOylation site prevents the tumorigenic capacity seen with wild-type YAP1, indicating the process is required for SENP3-dependent effects.\"}]","SENP3 mediates the deSUMOylation and degradation of YAP1 to regulate the progression of triple-negative breast cancer - Research Article | PDF",1790051393,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d181912f3952e9fac183f05dd0e781a9.webp",983,1296,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff80d9bf2f3750babac13b96d0d42065.webp",982,1294,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8e0f49481a217af094cd84fb908adaea.webp",981,1293,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b462d7f88a6427b1dafea23a28813dd3.webp",980,1292]